Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp. Ordinary Shares（DMAA）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · DMAA · 截至 2025年9月30日
股东结构概览
37
机构持有人数
▲ 5 vs Q2
$223.44M
机构持仓总市值
▲ $11.13M vs Q2
33.72M
总流通股
freeFloat 81.00%
21.76M
13F 申报持股数
▲ 934,127 vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
DMAA 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
KARPUS MANAGEMENT, INC. blank checks | 2.55M | 7.60% | 7.60% | $26.16B | Nov 14, 2025 | ▼ 196.4K |
FIRST TRUST CAPITAL MANAGEMENT L.P. blank checks | 2.24M | 6.69% | 6.69% | $23.03B | Nov 17, 2025 | — held |
POLAR ASSET MANAGEMENT PARTNERS INC. blank checks | 1.90M | 5.67% | 5.67% | $19.51B | Dec 1, 2025 | — held |
GLAZER CAPITAL, LLC blank checks | 1.82M | 5.44% | 5.44% | $18.71B | Nov 13, 2025 | ▼ 158 |
WESTCHESTER CAPITAL MANAGEMENT, LLC blank checks | 1.67M | 4.98% | 4.98% | $17.14B | Nov 14, 2025 | — held |
HUDSON BAY CAPITAL MANAGEMENT LP blank checks | 1.55M | 4.62% | 4.62% | $15.92B | Dec 15, 2025 | ▼ 250.0K |
WOLVERINE ASSET MANAGEMENT LLC blank checks | 1.25M | 3.73% | 3.73% | $12.83B | Oct 28, 2025 | ▲ 227.2K |
MIZUHO SECURITIES USA LLC blank checks | 1.10M | 3.28% | 3.28% | $11.29B | Oct 22, 2025 | ▲ 180.7K |
ARISTEIA CAPITAL LLC blank checks | 881.7K | 2.63% | 2.63% | $9.06B | Nov 14, 2025 | — held |
D. E. SHAW & CO., INC. blank checks | 690.0K | 2.06% | 2.06% | $7.09B | Nov 14, 2025 | — held |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
7
增持
+952.4K 股10
新建仓
首次建仓9
减持
−716.8K 股5
清仓
完全退出净股数变化（前50家）
+235.6K
+952.4K / −716.8K
净新增持仓人
+3
新建 10 个 / 退出 5 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
DMAA 内幕交易记录
数据来源：SEC Form 4
近期内部人员净买入。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
12
买入笔数
4
卖出笔数
3.00
买卖比
$12M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Drugs Made In America Acquisition LLC 10 percent owner | Feb 18, 2025 | Purchase | 30,000 | — | — | 4.19M | Form 4 ↗ |
Drugs Made In America Acquisition LLC 10 percent owner | Feb 18, 2025 | Purchase | 30,000 | — | — | 430.0K | Form 4 ↗ |
Stockwell Lynn CEO and Exe. Chair of Board | Feb 18, 2025 | Purchase | 30,000 | — | — | 4.19M | Form 4 ↗ |
Stockwell Lynn CEO and Exe. Chair of Board | Feb 18, 2025 | Purchase | 30,000 | — | — | 430.0K | Form 4 ↗ |
Drugs Made In America Acquisition LLC 10 percent owner | Jan 29, 2025 | Purchase | 400,000 | — | — | 10.26M | Form 4 ↗ |
Drugs Made In America Acquisition LLC 10 percent owner | Jan 29, 2025 | J-Other | 400,000 | — | — | 9.86M | Form 4 ↗ |
Drugs Made In America Acquisition LLC 10 percent owner | Jan 29, 2025 | Sale | 5,698,363 | $1.50 | $8.55M | 4.16M | Form 4 ↗ |
Drugs Made In America Acquisition LLC 10 percent owner | Jan 29, 2025 | Purchase | 400,000 | — | — | 400.0K | Form 4 ↗ |
Stockwell Lynn CEO and Executive COB | Jan 29, 2025 | J-Other | 400,000 | — | — | 9.86M | Form 4 ↗ |
Stockwell Lynn CEO and Executive COB | Jan 29, 2025 | Sale | 5,698,363 | $1.50 | $8.55M | 4.16M | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Drugs Made In America Acquisition Corp. Ordinary Shares（DMAA）主要由机构投资者持有，机构持股比例约为 64.5%。公司内部人员持股约 19.00%，散户及公众持股约占剩余的 16.47%。
Drugs Made In America Acquisition Corp. Ordinary Shares 最大机构股东为 KARPUS MANAGEMENT, INC.，截至 September 30, 2025 持有约 2.55 million 股，占总流通股的 7.60%。
目前共有 37 家机构持有 DMAA 股票，合计持仓市值约 $223,437,341，数据来源为最新 SEC 13F 申报。
常见问题
DMAA ownershipDrugs Made In America Acquisition Corp. Ordinary Shares（DMAA）主要由机构投资者持有，机构持股约 64.5%。最大股东为 KARPUS MANAGEMENT, INC.，持股比例 7.60%。内部人员持股约 19.00%。数据来源 SEC Form 13F，截至 September 30, 2025。